Pharma Mar Akcia Analýza akcií | Cena akcií | Novinky | PHM.MC | ES0169501022 | A2P9YT

Dátum	Pharma Mar Tržby	Pharma Mar EBIT	Pharma Mar Zisk
2028e	465,20 mil. undefined	308,01 mil. undefined	223,25 mil. undefined
2027e	228,81 mil. undefined	99,98 mil. undefined	131,82 mil. undefined
2026e	176,75 mil. undefined	54,00 mil. undefined	46,67 mil. undefined
2025e	160,71 mil. undefined	31,96 mil. undefined	38,42 mil. undefined
2024e	156,84 mil. undefined	-2,13 mil. undefined	1,30 mil. undefined
2023	158,15 mil. undefined	-4,10 mil. undefined	1,14 mil. undefined
2022	196,34 mil. undefined	44,44 mil. undefined	49,36 mil. undefined
2021	229,83 mil. undefined	92,35 mil. undefined	92,86 mil. undefined
2020	269,96 mil. undefined	156,21 mil. undefined	137,26 mil. undefined
2019	85,82 mil. undefined	-17,48 mil. undefined	-11,38 mil. undefined
2018	108,77 mil. undefined	-16,03 mil. undefined	-5,54 mil. undefined
2017	158,88 mil. undefined	-19,54 mil. undefined	-26,75 mil. undefined
2016	180,95 mil. undefined	-18,71 mil. undefined	-24,08 mil. undefined
2015	193,82 mil. undefined	11,30 mil. undefined	6,59 mil. undefined
2014	174,80 mil. undefined	20,24 mil. undefined	13,12 mil. undefined
2013	141,82 mil. undefined	18,96 mil. undefined	11,32 mil. undefined
2012	161,78 mil. undefined	14,57 mil. undefined	6,59 mil. undefined
2011	177,20 mil. undefined	23,85 mil. undefined	4,74 mil. undefined
2010	161,24 mil. undefined	-9,52 mil. undefined	-7,35 mil. undefined
2009	143,63 mil. undefined	-21,20 mil. undefined	-25,88 mil. undefined
2008	122,85 mil. undefined	-37,06 mil. undefined	-40,65 mil. undefined
2007	99,87 mil. undefined	-45,33 mil. undefined	-45,08 mil. undefined
2006	87,36 mil. undefined	-48,01 mil. undefined	-43,82 mil. undefined
2005	82,39 mil. undefined	-39,30 mil. undefined	-37,75 mil. undefined
2004	94,66 mil. undefined	-21,85 mil. undefined	-20,67 mil. undefined

	Tržby	EBIT	Zisk
2004	94,66 mil. EUR	-21,85 mil. EUR	-20,67 mil. EUR
2005	82,39 mil. EUR	-39,30 mil. EUR	-37,75 mil. EUR
2006	87,36 mil. EUR	-48,01 mil. EUR	-43,82 mil. EUR
2007	99,87 mil. EUR	-45,33 mil. EUR	-45,08 mil. EUR
2008	122,85 mil. EUR	-37,06 mil. EUR	-40,65 mil. EUR
2009	143,63 mil. EUR	-21,20 mil. EUR	-25,88 mil. EUR
2010	161,24 mil. EUR	-9,52 mil. EUR	-7,35 mil. EUR
2011	177,20 mil. EUR	23,85 mil. EUR	4,74 mil. EUR
2012	161,78 mil. EUR	14,57 mil. EUR	6,59 mil. EUR
2013	141,82 mil. EUR	18,96 mil. EUR	11,32 mil. EUR
2014	174,80 mil. EUR	20,24 mil. EUR	13,12 mil. EUR
2015	193,82 mil. EUR	11,30 mil. EUR	6,59 mil. EUR
2016	180,95 mil. EUR	-18,71 mil. EUR	-24,08 mil. EUR
2017	158,88 mil. EUR	-19,54 mil. EUR	-26,75 mil. EUR
2018	108,77 mil. EUR	-16,03 mil. EUR	-5,54 mil. EUR
2019	85,82 mil. EUR	-17,48 mil. EUR	-11,38 mil. EUR
2020	269,96 mil. EUR	156,21 mil. EUR	137,26 mil. EUR
2021	229,83 mil. EUR	92,35 mil. EUR	92,86 mil. EUR
2022	196,34 mil. EUR	44,44 mil. EUR	49,36 mil. EUR
2023	158,15 mil. EUR	-4,10 mil. EUR	1,14 mil. EUR
2024e	156,84 mil. EUR	-2,13 mil. EUR	1,30 mil. EUR
2025e	160,71 mil. EUR	31,96 mil. EUR	38,42 mil. EUR
2026e	176,75 mil. EUR	54,00 mil. EUR	46,67 mil. EUR
2027e	228,81 mil. EUR	99,98 mil. EUR	131,82 mil. EUR
2028e	465,20 mil. EUR	308,01 mil. EUR	223,25 mil. EUR

Pharma Mar Hrubá marža	Pharma Mar Marža zisku	Pharma Mar EBIT marža	Pharma Mar Marža zisku
2028e	93,92 %	66,21 %	47,99 %
2027e	93,92 %	43,69 %	57,61 %
2026e	93,92 %	30,55 %	26,40 %
2025e	93,92 %	19,89 %	23,91 %
2024e	93,92 %	-1,35 %	0,83 %
2023	93,92 %	-2,59 %	0,72 %
2022	93,05 %	22,63 %	25,14 %
2021	92,85 %	40,18 %	40,40 %
2020	94,92 %	57,86 %	50,85 %
2019	93,91 %	-20,36 %	-13,26 %
2018	95,47 %	-14,74 %	-5,09 %
2017	78,01 %	-12,30 %	-16,83 %
2016	75,70 %	-10,34 %	-13,31 %
2015	76,42 %	5,83 %	3,40 %
2014	76,68 %	11,58 %	7,50 %
2013	76,37 %	13,37 %	7,98 %
2012	77,51 %	9,00 %	4,08 %
2011	77,42 %	13,46 %	2,68 %
2010	72,50 %	-5,90 %	-4,56 %
2009	69,95 %	-14,76 %	-18,02 %
2008	68,64 %	-30,16 %	-33,09 %
2007	61,73 %	-45,39 %	-45,14 %
2006	61,76 %	-54,96 %	-50,16 %
2005	65,37 %	-47,71 %	-45,82 %
2004	63,29 %	-23,08 %	-21,83 %

	Hrubá marža	EBIT marža	Marža zisku
2004	63,29 %	-23,08 %	-21,83 %
2005	65,37 %	-47,71 %	-45,82 %
2006	61,76 %	-54,96 %	-50,16 %
2007	61,73 %	-45,39 %	-45,14 %
2008	68,64 %	-30,16 %	-33,09 %
2009	69,95 %	-14,76 %	-18,02 %
2010	72,50 %	-5,90 %	-4,56 %
2011	77,42 %	13,46 %	2,68 %
2012	77,51 %	9,00 %	4,08 %
2013	76,37 %	13,37 %	7,98 %
2014	76,68 %	11,58 %	7,50 %
2015	76,42 %	5,83 %	3,40 %
2016	75,70 %	-10,34 %	-13,31 %
2017	78,01 %	-12,30 %	-16,83 %
2018	95,47 %	-14,74 %	-5,09 %
2019	93,91 %	-20,36 %	-13,26 %
2020	94,92 %	57,86 %	50,85 %
2021	92,85 %	40,18 %	40,40 %
2022	93,05 %	22,63 %	25,14 %
2023	93,92 %	-2,59 %	0,72 %
2024e	93,92 %	-1,35 %	0,83 %
2025e	93,92 %	19,89 %	23,91 %
2026e	93,92 %	30,55 %	26,40 %
2027e	93,92 %	43,69 %	57,61 %
2028e	93,92 %	66,21 %	47,99 %

Dátum	Pharma Mar Tržby na akciu	Pharma Mar EBIT na akciu	Pharma Mar Zisk na akciu
2028e	26,08 undefined	0 undefined	12,51 undefined
2027e	12,83 undefined	0 undefined	7,39 undefined
2026e	9,91 undefined	0 undefined	2,62 undefined
2025e	9,01 undefined	0 undefined	2,15 undefined
2024e	8,79 undefined	0 undefined	0,07 undefined
2023	8,83 undefined	-0,23 undefined	0,06 undefined
2022	10,87 undefined	2,46 undefined	2,73 undefined
2021	12,71 undefined	5,11 undefined	5,13 undefined
2020	14,73 undefined	8,52 undefined	7,49 undefined
2019	4,64 undefined	-0,94 undefined	-0,62 undefined
2018	5,90 undefined	-0,87 undefined	-0,30 undefined
2017	8,62 undefined	-1,06 undefined	-1,45 undefined
2016	9,84 undefined	-1,02 undefined	-1,31 undefined
2015	10,51 undefined	0,61 undefined	0,36 undefined
2014	9,51 undefined	1,10 undefined	0,71 undefined
2013	7,70 undefined	1,03 undefined	0,61 undefined
2012	8,81 undefined	0,79 undefined	0,36 undefined
2011	9,59 undefined	1,29 undefined	0,26 undefined
2010	8,79 undefined	-0,52 undefined	-0,40 undefined
2009	7,87 undefined	-1,16 undefined	-1,42 undefined
2008	6,74 undefined	-2,03 undefined	-2,23 undefined
2007	5,56 undefined	-2,52 undefined	-2,51 undefined
2006	4,93 undefined	-2,71 undefined	-2,47 undefined
2005	4,76 undefined	-2,27 undefined	-2,18 undefined
2004	5,51 undefined	-1,27 undefined	-1,20 undefined

	Tržby na akciu	EBIT na akciu	Zisk na akciu
2004	5,51 EUR	-1,27 EUR	-1,20 EUR
2005	4,76 EUR	-2,27 EUR	-2,18 EUR
2006	4,93 EUR	-2,71 EUR	-2,47 EUR
2007	5,56 EUR	-2,52 EUR	-2,51 EUR
2008	6,74 EUR	-2,03 EUR	-2,23 EUR
2009	7,87 EUR	-1,16 EUR	-1,42 EUR
2010	8,79 EUR	-0,52 EUR	-0,40 EUR
2011	9,59 EUR	1,29 EUR	0,26 EUR
2012	8,81 EUR	0,79 EUR	0,36 EUR
2013	7,70 EUR	1,03 EUR	0,61 EUR
2014	9,51 EUR	1,10 EUR	0,71 EUR
2015	10,51 EUR	0,61 EUR	0,36 EUR
2016	9,84 EUR	-1,02 EUR	-1,31 EUR
2017	8,62 EUR	-1,06 EUR	-1,45 EUR
2018	5,90 EUR	-0,87 EUR	-0,30 EUR
2019	4,64 EUR	-0,94 EUR	-0,62 EUR
2020	14,73 EUR	8,52 EUR	7,49 EUR
2021	12,71 EUR	5,11 EUR	5,13 EUR
2022	10,87 EUR	2,46 EUR	2,73 EUR
2023	8,83 EUR	-0,23 EUR	0,06 EUR
2024e	8,79 EUR	0 EUR	0,07 EUR
2025e	9,01 EUR	0 EUR	2,15 EUR
2026e	9,91 EUR	0 EUR	2,62 EUR
2027e	12,83 EUR	0 EUR	7,39 EUR
2028e	26,08 EUR	0 EUR	12,51 EUR

	Počet akcií
2004	17,18 mil. Aktien
2005	17,31 mil. Aktien
2006	17,72 mil. Aktien
2007	17,97 mil. Aktien
2008	18,22 mil. Aktien
2009	18,25 mil. Aktien
2010	18,35 mil. Aktien
2011	18,48 mil. Aktien
2012	18,36 mil. Aktien
2013	18,42 mil. Aktien
2014	18,39 mil. Aktien
2015	18,44 mil. Aktien
2016	18,38 mil. Aktien
2017	18,44 mil. Aktien
2018	18,44 mil. Aktien
2019	18,50 mil. Aktien
2020	18,33 mil. Aktien
2021	18,09 mil. Aktien
2022	18,06 mil. Aktien
2023	17,92 mil. Aktien
2024e	17,92 mil. Aktien
2025e	17,92 mil. Aktien
2026e	17,92 mil. Aktien
2027e	17,92 mil. Aktien
2028e	17,92 mil. Aktien

Dátum	Pharma Mar Dividenda
2028e	0,77 undefined
2027e	0,77 undefined
2026e	0,77 undefined
2025e	0,77 undefined
2024e	0,77 undefined
2023	0,65 undefined
2022	0,65 undefined
2021	0,60 undefined
2020	0,48 undefined
2008	0,06 undefined
2007	0,06 undefined
2004	0,12 undefined

	Dividenda	Dividenda (odhad)
2004	0,12 EUR	0 EUR
2005	0 EUR	0 EUR
2006	0 EUR	0 EUR
2007	0,06 EUR	0 EUR
2008	0,06 EUR	0 EUR
2009	0 EUR	0 EUR
2010	0 EUR	0 EUR
2011	0 EUR	0 EUR
2012	0 EUR	0 EUR
2013	0 EUR	0 EUR
2014	0 EUR	0 EUR
2015	0 EUR	0 EUR
2016	0 EUR	0 EUR
2017	0 EUR	0 EUR
2018	0 EUR	0 EUR
2019	0 EUR	0 EUR
2020	0,48 EUR	0 EUR
2021	0,60 EUR	0 EUR
2022	0,65 EUR	0 EUR
2023	0,65 EUR	0 EUR
2024e	0 EUR	0,77 EUR
2025e	0 EUR	0,77 EUR
2026e	0 EUR	0,77 EUR
2027e	0 EUR	0,77 EUR
2028e	0 EUR	0,77 EUR

Dátum	Pharma Mar Výplatný pomer
2028e	17,07 %
2027e	16,92 %
2026e	16,18 %
2025e	18,09 %
2024e	16,49 %
2023	13,97 %
2022	23,81 %
2021	11,70 %
2020	6,41 %
2019	13,97 %
2018	13,97 %
2017	13,97 %
2016	13,97 %
2015	13,97 %
2014	13,97 %
2013	13,97 %
2012	13,97 %
2011	13,97 %
2010	13,97 %
2009	13,97 %
2008	-2,69 %
2007	-2,39 %
2006	13,97 %
2005	13,97 %
2004	-9,80 %

	Výplatný pomer
2004	-9,80 %
2005	13,97 %
2006	13,97 %
2007	-2,39 %
2008	-2,69 %
2009	13,97 %
2010	13,97 %
2011	13,97 %
2012	13,97 %
2013	13,97 %
2014	13,97 %
2015	13,97 %
2016	13,97 %
2017	13,97 %
2018	13,97 %
2019	13,97 %
2020	6,41 %
2021	11,70 %
2022	23,81 %
2023	13,97 %
2024e	16,49 %
2025e	18,09 %
2026e	16,18 %
2027e	16,92 %
2028e	17,07 %

Dátum	Odhad EPS	EPS-Aktuálny	spravodajské štvrťrok
30. 6. 2018	-0,36	0,12 (133,00 %)	2018 Q2

%	Meno	Akciové spoločnosti	Zmena	Dátum
6,25 %	Fernandez Sousa Faro (Jose Maria)	1 114 147	0	10. 8. 2023
5,35 %	Andrade Detrell (Montserrat)	954 460	0	10. 8. 2023
5,20 %	Ortega Mera (Sandra)	927 705	0	10. 8. 2023
5,15 %	Fernandez Puentes (Pedro Francisco)	917 979	0	10. 8. 2023
2,06 %	The Vanguard Group, Inc.	368 173	-19 507	31. 3. 2024
1,17 %	BlackRock Institutional Trust Company, N.A.	208 023	170	31. 3. 2024
1,13 %	Norges Bank Investment Management (NBIM)	201 527	-59 564	31. 12. 2023
1,10 %	Redwheel	196 406	0	10. 8. 2023
0,49 %	Dimensional Fund Advisors, L.P.	86 609	0	31. 3. 2024
0,39 %	BlackRock Advisors (UK) Limited	68 754	-1 593	31. 3. 2024
0,34 %	Jupiter Asset Management Ltd.	61 134	0	31. 12. 2023
0,30 %	State Street Global Advisors (US)	54 116	0	31. 3. 2024
0,29 %	Old Mutual Investment Group (South Africa) (Pty) Limited	51 019	-1 950	30. 6. 2023
0,18 %	Caixabank Asset Management SGIIC, S.A.U.	31 715	29 026	31. 12. 2023
0,18 %	Credit Suisse Funds AG	31 709	-6 600	29. 2. 2024
0,13 %	Charles Schwab Investment Management, Inc.	22 378	-3 975	31. 3. 2024
0,12 %	Mellon Investments Corporation	20 914	280	31. 3. 2024
0,11 %	DWS Investment GmbH	18 887	1 024	29. 2. 2024
0,09 %	Legal & General Investment Management Ltd.	16 778	-5 388	31. 3. 2024
0,09 %	California State Teachers Retirement System	15 973	-66	30. 6. 2023
0,08 %	Urquijo Gestión, S.A., S.G.I.I.C., Sociedad Unipersonal	15 000	0	31. 12. 2023
0,07 %	Amundi Asset Management, SAS	12 518	0	31. 3. 2024
0,07 %	Geode Capital Management, L.L.C.	12 054	0	29. 2. 2024
0,07 %	Nuveen LLC	11 994	0	31. 3. 2024
0,06 %	Serra Rexach (Eduardo)	11 013	0	31. 12. 2022
0,06 %	Dimensional Fund Advisors, Ltd.	10 007	528	31. 1. 2024
0,04 %	Credit Suisse Asset Management (Schweiz) AG	8 019	0	29. 2. 2024
0,04 %	Consultinvest Asset Management SGR S.p.A.	7 500	0	30. 9. 2023
0,04 %	Andbank Wealth Management, SGIIC, S.A.U.	6 930	0	31. 8. 2023
0,03 %	UBS Asset Management (Switzerland)	5 288	0	31. 3. 2024
0,03 %	State Street Global Advisors Ireland Limited	5 046	-1 066	31. 3. 2024
0,03 %	Zürcher Kantonalbank (Asset Management)	4 873	0	31. 1. 2024
0,03 %	BlackRock Asset Management Canada Limited	4 494	0	31. 3. 2024
0,02 %	BlackRock Financial Management, Inc.	4 272	-3 397	30. 11. 2023
0,02 %	Florida State Board of Administration	4 243	-4 204	30. 9. 2022
0,02 %	Mercer Global Investments Management Ltd	4 088	0	31. 3. 2024
0,02 %	Mirae Asset Global Investments (USA) LLC	3 649	95	31. 3. 2024
0,02 %	Irish Life Investment Managers Ltd.	3 472	319	31. 3. 2024
0,02 %	Northern Trust Global Investments Limited	3 402	0	31. 12. 2023
0,02 %	Caja Laboral Gestión S.G.I.I.C., S.A.	3 329	2 886	31. 12. 2023
0,02 %	Unigest, S.G.I.I.C., S.A.	3 095	1 321	31. 3. 2023
0,01 %	KLP Fondsforvaltning AS	2 626	0	29. 2. 2024
0,01 %	Vanguard Investments Australia Ltd.	2 578	-2	29. 2. 2024
0,01 %	Renta 4 Gestora, S.G.I.I.C., S.A.	2 500	-1 731	31. 12. 2023
0,01 %	ANDBANK Asset Management Luxembourg SA	2 100	0	30. 6. 2023
0,01 %	Greiff capital management AG	1 961	-499	31. 3. 2023
0,01 %	BlackRock Investment Management (UK) Ltd.	1 866	0	31. 12. 2023
0,01 %	Hernandez Rodriguez (Blanca)	1 855	-1 816	31. 12. 2022
0,01 %	Nykredit Bank AS	1 092	126	29. 2. 2024
0,01 %	Hussman Strategic Advisors, Inc.	1 000	0	31. 3. 2023
0,01 %	UniCredit International Bank (Luxembourg) S.A.	981	981	31. 12. 2022
0,00 %	Pictet Asset Management Ltd.	850	0	30. 11. 2023
0,00 %	Euroagentes Gestión S.G.I.I.C., S.A.	846	846	30. 9. 2023
0,00 %	Inversis Gestión, S.A., SGIIC	832	294	31. 3. 2023
0,00 %	DFA Australia Ltd.	715	-311	31. 12. 2023
0,00 %	Vanguard Global Advisers LLC	688	0	31. 3. 2024
0,00 %	UBS Asset Management (UK) Ltd.	520	0	29. 2. 2024
0,00 %	Danske Bank Asset Management	461	-3 906	31. 12. 2023
0,00 %	Dimensional Fund Advisors Canada ULC	320	0	30. 11. 2023
0,00 %	Sumitomo Mitsui Trust Asset Management Co., Ltd.	295	-5	31. 3. 2023
0,00 %	Anfield Capital Management, LLC	263	0	31. 12. 2022
0,00 %	American Century Investment Management, Inc.	261	0	31. 3. 2024
0,00 %	Sanchez-Yebra Alonso (Rosa Maria)	184	184	31. 12. 2022
0,00 %	DBX Advisors LLC.	83	-10	29. 2. 2024
0,00 %	BMO Asset Management Inc.	28	0	30. 11. 2023
0 %	Rayliant Global Advisors	0	-3 001	30. 9. 2022
0 %	Finlabo SIM S.p. A.	0	-5 500	31. 8. 2022
0 %	Legato Capital Management LLC	0	-3 481	30. 9. 2022
0 %	UNIQA Towarzystwo Funduszy Inwestycyjnych S. A	0	-4 900	31. 12. 2022
0 %	Aramea Asset Management AG	0	-9 000	31. 3. 2023
0 %	Perinvest (UK) Ltd.	0	-5 260	31. 12. 2022
0 %	BG Fund Management Luxembourg S.A.	0	-5 857	31. 1. 2024
0 %	Mediolanum International Funds Limited	0	-855	30. 6. 2023
0 %	Gesiuris Asset Management S.G.I.I.C., S.A.	0	-2 785	30. 6. 2023
0 %	FIL Investment Management (Australia) Limited	0	-221	31. 12. 2022
0 %	SEI Investments Management Corporation	0	-3 994	31. 5. 2023
0 %	AMUNDI IBERIA SGIIC SA	0	-13 846	30. 6. 2023
0 %	Montepio Gestão de Activos - SGFI, S.A.	0	-833	30. 4. 2023
0 %	Imantia Capital	0	-562	31. 12. 2023
0 %	Gescooperativo, S.A., S.G.I.I.C.	0	-2 000	30. 6. 2023
0 %	Santander Asset Management	0	-276 581	30. 6. 2023
0 %	Sabadell Asset Management, S.A., S.G.I.I.C., Sociedad Unipersonal	0	-61 016	30. 6. 2023
0 %	Allianz Popular Asset Management, SGIIC, S.A.	0	-538	31. 12. 2023
0 %	BBVA Asset Management, S.A., S.G.I.I.C.	0	-12 755	30. 6. 2023
0 %	GVC Gaesco Gestión SGIIC S.A.	0	-2 600	31. 3. 2023
0 %	FIL Investment Management (Hong Kong) Limited	0	-2 531	30. 11. 2022
0 %	Baillie Gifford & Co.	0	-3 817	31. 1. 2024
0 %	Fidelity International	0	-19 282	31. 12. 2022
0 %	Union Bancaire Privée	0	-3 806	31. 8. 2023
0 %	Handelsbanken Kapitalförvaltning AB	0	-1 464	31. 5. 2023
0 %	Robeco Institutional Asset Management B.V.	0	-1 797	30. 4. 2023
0 %	Rockefeller Capital Management	0	-306	31. 3. 2024
0 %	Thrivent Asset Management, LLC	0	-2 343	31. 10. 2023
0 %	Lazard Asset Management, L.L.C.	0	-579	31. 8. 2022
0 %	Victory Capital Management Inc.	0	-1 482	30. 6. 2023
0 %	Northern Trust Investments, Inc.	0	-824	31. 12. 2023
0 %	AllianceBernstein L.P.	0	-44 165	30. 4. 2023
0 %	Goldman Sachs Asset Management, L.P.	0	-31 393	30. 4. 2023
0 %	Avantis Investors	0	-29 153	30. 6. 2023

What values and corporate philosophy does Pharma Mar represent?

Pharma Mar SA represents a set of core values and corporate philosophy that drive its operations. The company focuses on developing innovative therapies in the field of oncology and the treatment of other serious diseases. With a commitment to scientific excellence, Pharma Mar SA aims to create impactful solutions that improve patients' lives. Through strategic collaborations and continuous research, the company strives to deliver cutting-edge pharmaceutical products. Pharma Mar SA's dedication to ethical practices, transparency, and sustainability further reinforces its commitment to stakeholders and the global healthcare community.

In which countries and regions is Pharma Mar primarily present?

Pharma Mar SA is primarily present in several countries and regions. The company has a strong presence in Spain, where it is based and operates its headquarters. Additionally, Pharma Mar SA has expanded its operations to various international markets, including the United States, Germany, Italy, France, and Switzerland. With a global presence, Pharma Mar SA strives to bring its innovative pharmaceutical products and treatments to patients worldwide.

What significant milestones has the company Pharma Mar achieved?

Pharma Mar SA, a leading pharmaceutical company, has achieved significant milestones in its remarkable journey. The company's innovative approach and dedication to drug discovery have yielded remarkable results. Pharma Mar SA's milestones include successful clinical trials for their flagship drugs, receiving regulatory approvals, and securing strategic partnerships with renowned pharmaceutical companies. Furthermore, the company's consistent commitment to scientific research and development has resulted in groundbreaking discoveries that have revolutionized the treatment of various diseases. Through their remarkable achievements, Pharma Mar SA has solidified its position as a pioneering force in the pharmaceutical industry and continues to make invaluable contributions towards improving global healthcare.

What is the history and background of the company Pharma Mar?

Pharma Mar SA is a leading biopharmaceutical company with a rich history and background. Established in 1986, the company is headquartered in Madrid, Spain. Pharma Mar SA focuses on the research, development, and commercialization of innovative marine-derived drugs to address various oncology and rare diseases. With a strong commitment to scientific excellence, Pharma Mar SA has built a diverse pipeline of potential therapies, leveraging the unique properties of marine organisms. The company has garnered global recognition for its breakthrough discovery of marine-derived compounds, including the development of Aplidin® (plitidepsin), a promising anticancer agent undergoing clinical trials. Pharma Mar SA continues to push boundaries in the pharmaceutical industry, striving to improve patients' lives worldwide.

Who are the main competitors of Pharma Mar in the market?

The main competitors of Pharma Mar SA in the market include other pharmaceutical companies operating in the same field and targeting similar market segments. Some notable competitors of Pharma Mar SA may include (examples only, not an exhaustive list): AstraZeneca, Novartis, Roche Holding, Pfizer, and Johnson & Johnson. These companies also focus on researching, developing, and marketing pharmaceutical products, including therapies and treatment options.

In which industries is Pharma Mar primarily active?

Pharma Mar SA is primarily active in the pharmaceutical industry.

What is the business model of Pharma Mar?

The business model of Pharma Mar SA revolves around the research, development, and commercialization of innovative marine-derived pharmaceutical products. Pharma Mar specializes in the development of therapies derived from marine resources, particularly marine microorganisms. By harnessing the therapeutic potential of the sea, the company aims to bring effective treatments to patients suffering from various diseases, including cancer. With a focus on oncology, Pharma Mar seeks to address unmet medical needs and improve patients' lives globally. Through strategic partnerships, clinical trials, and ongoing research, Pharma Mar continues to drive advancements in the field of marine-derived pharmaceuticals.

Aké P/E má Pharma Mar 2024?

Pomer Pharma Mar cena/zisk je 444,70.

Aké KUV má Pharma Mar 2024?

Koeficient Pharma Mar P/S je 3,68.

Aký AlleAktien kvalitatívny skóre má Pharma Mar?

AlleAktien kvalitatívne skóre pre Pharma Mar je 1/10.

Aká je výška tržieb spoločnosti Pharma Mar 2024?

Tržby spoločnosti očakávaná Pharma Mar sú 156,84 mil. EUR.

Aká je výška zisku spoločnosti Pharma Mar 2024?

Zisk očakávaná Pharma Mar je 1,30 mil. EUR.

Čo robí Pharma Mar?

Pharma-Mar SA is a Spanish pharmaceutical company specializing in the development and marketing of cancer therapies. The company was founded in 1986 and is based in Colmenar Viejo, near Madrid. The company consists of two different business areas: Oncology and Consumer Healthcare. The Oncology division focuses on the development and marketing of innovative cancer drugs based on marine compounds, while the Consumer Healthcare division distributes over-the-counter drugs and cosmetic products. The company's business model is based on a strong research and development department that specializes in the exploration and development of cancer drugs based on marine compounds. They also collaborate with other pharmaceutical companies and research institutions to advance the research and development of cancer drugs. The company has a strong presence in international markets and has distribution partnerships in Europe, America, and Asia, allowing them to market their products worldwide and increase their revenue. Overall, Pharma-Mar SA is dedicated to the research, development, and distribution of cancer drugs, as well as over-the-counter drugs and cosmetic products.

Aká vysoká je Pharma Mar dividenda?

Pharma Mar vypláca dividendu vo výške 0,65 EUR rozdelenú do výplat počas roka.

Ako často vypláca Pharma Mar dividendu?

Dividenda pre Pharma Mar sa aktuálne nedá vypočítať alebo spoločnosť nevypláca dividendu.

Aká je Pharma Mar ISIN?

ISIN spoločnosti Pharma Mar je ES0169501022.

Čo je to Pharma Mar WKN?

WKN spoločnosti Pharma Mar je A2P9YT.

Aký je Pharma Mar ticker?

Ticker spoločnosti Pharma Mar je PHM.MC.

Akú dividendu platí Pharma Mar?

V posledných 12 mesiacoch spoločnosť Pharma Mar vyplatila dividendu vo výške 0,65 EUR . To zodpovedá dividendovému výnosu približne 2,02 %. Pre nadchádzajúcich 12 mesiacov bude pravdepodobne spoločnosť Pharma Mar vyplácať dividendu 0,77 EUR.

Aká je dividendová výnosnosť spoločnosti Pharma Mar?

Súčasný výnos z dividend spoločnosti Pharma Mar je 2,02 %.

Kedy vypláca Pharma Mar dividendu?

Pharma Mar vypláca dividendu každý štvrťrok. Tá je vyplácaná v mesiacoch máj, august, júl, júl.

Ako istá je dividenda spoločnosti Pharma Mar?

Pharma Mar platil každý rok počas posledných 9 rokov dividendu.

Aká vysoká je dividenda spoločnosti Pharma Mar?

Na nasledujúcich 12 mesiacov sa očakávajú dividendy vo výške 0,77 EUR. To zodpovedá dividendovému výnosu 2,33 %.

V ktorom sektore sa nachádza Pharma Mar?

Pharma Mar je priradený sektoru 'Zdravie'.

Wann musste ich die Aktien von Pharma Mar kaufen, um die vorherige Dividende zu erhalten?

Aby ste obdržali poslednú dividendu vo výške 0,65 EUR od Pharma Mar z dňa 14. 6. 2024, museli ste mať akciu v depozite pred ex-dňom 12. 6. 2024.

Kedy poslednýkrát Pharma Mar vyplatil dividendu?

Posledná dividenda bola vyplatená 14. 6. 2024.

Aká bola dividenda spoločnosti Pharma Mar v roku 2023?

V roku 2023 boli od Pharma Mar 0,65 EUR vyplatené ako dividendy.

V akej mene vypláca Pharma Mar dividendu?

Dividendy spoločnosti Pharma Mar sú vyplácané v EUR.

1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e
32,00	33,00	36,00	39,00	48,00	56,00	84,00	69,00	76,00	94,00	82,00	87,00	99,00	122,00	143,00	161,00	177,00	161,00	141,00	174,00	193,00	180,00	158,00	108,00	85,00	269,00	229,00	196,00	158,00	156,00	160,00	176,00	228,00	465,00
-	3,13	9,09	8,33	23,08	16,67	50,00	-17,86	10,14	23,68	-12,77	6,10	13,79	23,23	17,21	12,59	9,94	-9,04	-12,42	23,40	10,92	-6,74	-12,22	-31,65	-21,30	216,47	-14,87	-14,41	-19,39	-1,27	2,56	10,00	29,55	103,95
71,88	69,70	66,67	69,23	72,92	91,07	100,00	117,39	117,11	62,77	64,63	60,92	61,62	68,85	69,93	72,05	77,40	77,64	76,60	77,01	76,68	75,56	77,85	95,37	94,12	95,17	93,01	92,86	93,67	-	-	-	-	-
23,00	23,00	24,00	27,00	35,00	51,00	84,00	81,00	89,00	59,00	53,00	53,00	61,00	84,00	100,00	116,00	137,00	125,00	108,00	134,00	148,00	136,00	123,00	103,00	80,00	256,00	213,00	182,00	148,00	0	0	0	0	0
1,00	3,00	1,00	3,00	5,00	4,00	-4,00	0	-23,00	-21,00	-39,00	-48,00	-45,00	-37,00	-21,00	-9,00	23,00	14,00	18,00	20,00	11,00	-18,00	-19,00	-16,00	-17,00	156,00	92,00	44,00	-4,00	-2,00	31,00	53,00	99,00	308,00
3,13	9,09	2,78	7,69	10,42	7,14	-4,76	-	-30,26	-22,34	-47,56	-55,17	-45,45	-30,33	-14,69	-5,59	12,99	8,70	12,77	11,49	5,70	-10,00	-12,03	-14,81	-20,00	57,99	40,17	22,45	-2,53	-1,28	19,38	30,11	43,42	66,24
1,00	1,00	1,00	3,00	9,00	12,00	9,00	4,00	2,00	-20,00	-37,00	-43,00	-45,00	-40,00	-25,00	-7,00	4,00	6,00	11,00	13,00	6,00	-24,00	-26,00	-5,00	-11,00	137,00	92,00	49,00	1,00	1,00	38,00	46,00	131,00	223,00
-	-	-	200,00	200,00	33,33	-25,00	-55,56	-50,00	-1 100,00	85,00	16,22	4,65	-11,11	-37,50	-72,00	-157,14	50,00	83,33	18,18	-53,85	-500,00	8,33	-80,77	120,00	-1 345,45	-32,85	-46,74	-97,96	-	3 700,00	21,05	184,78	70,23
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
14,24	14,24	14,24	14,24	11,30	12,58	17,32	17,40	17,40	17,18	17,31	17,72	17,97	18,22	18,25	18,35	18,48	18,36	18,42	18,39	18,44	18,38	18,44	18,44	18,50	18,33	18,09	18,06	17,92	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
-23,00	-21,00	-39,00	-48,00	-46,00	-42,00	-26,00	-14,00	1,00	-1,00	13,00	14,00	5,00	-24,00	-22,00	-7,00	-23,00	145,00	95,00	43,00	-3,00
18,00	5,00	5,00	5,00	5,00	5,00	5,00	5,00	5,00	5,00	4,00	5,00	6,00	7,00	7,00	6,00	6,00	7,00	5,00	5,00	5,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-16,00	5,00	11,00	-6,00	-7,00	-1,00	-3,00	-12,00	-9,00	3,00	2,00	-4,00	-7,00	2,00	8,00	-10,00	-16,00	115,00	-72,00	-27,00	-16,00
-51,00	-9,00	-10,00	-6,00	0	3,00	2,00	0	-2,00	-1,00	-3,00	7,00	6,00	6,00	6,00	-5,00	7,00	10,00	-2,00	15,00	1,00
4,00	0	0	0	0	1,00	0	0	0	0	0	6,00	6,00	5,00	5,00	4,00	2,00	3,00	3,00	2,00	2,00
0	0	0	0	0	0	2,00	0	0	0	0	0	0	0	-3,00	-7,00	0	9,00	7,00	-2,00	-16,00
-71,00	-21,00	-33,00	-56,00	-49,00	-35,00	-22,00	-21,00	-4,00	6,00	16,00	22,00	11,00	-8,00	-1,00	-16,00	-26,00	278,00	25,00	38,00	-13,00
-18,00	-3,00	-2,00	-4,00	-3,00	-8,00	-5,00	-3,00	-3,00	-2,00	-2,00	-10,00	-9,00	-6,00	-4,00	-2,00	-3,00	-3,00	-7,00	-8,00	-15,00
21,00	-17,00	-59,00	52,00	-19,00	27,00	-6,00	-3,00	5,00	0	10,00	-22,00	-28,00	13,00	5,00	22,00	32,00	-119,00	18,00	10,00	-43,00
39,00	-14,00	-57,00	57,00	-15,00	36,00	-1,00	0	8,00	2,00	12,00	-12,00	-19,00	19,00	10,00	24,00	35,00	-116,00	26,00	19,00	-27,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
18,00	3,00	-1,00	-4,00	10,00	16,00	13,00	17,00	1,00	-13,00	-17,00	1,00	0	1,00	3,00	-9,00	-12,00	-31,00	-9,00	-8,00	-1,00
0	0	54,00	25,00	40,00	-7,00	9,00	4,00	0	0	0	-2,00	6,00	0	0	0	1,00	-33,00	-7,00	7,00	-19,00
15,00	18,00	52,00	20,00	50,00	9,00	28,00	28,00	-11,00	-18,00	-23,00	-5,00	8,00	1,00	5,00	-7,00	-11,00	-73,00	-27,00	-13,00	-32,00
-1,00	14,00	0	0	0	0	5,00	5,00	-13,00	-5,00	-5,00	-4,00	2,00	0	1,00	3,00	0	0	0	0	0
-2,00	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-8,00	-10,00	-11,00	-11,00
-34,00	-20,00	-40,00	17,00	-17,00	1,00	0	3,00	-10,00	-12,00	4,00	-5,00	-8,00	6,00	9,00	-1,00	-5,00	78,00	17,00	36,00	-89,00
-89,96	-24,78	-35,28	-60,76	-53,02	-44,23	-28,31	-24,99	-7,34	4,29	14,25	12,61	1,88	-14,51	-6,12	-18,72	-30,05	275,94	17,87	29,47	-29,40
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Priame emisie	1 157
Nepriame emisie z nakúpenej energie	1 371
Nepriame emisie v rámci hodnotového reťazca	5 765
Emisie CO₂	2 528
Stratégia redukcie CO₂	✅
Uhlená energia	❌
Atómová energia	❌
Pokúsy na zvieratách	✅
Pelz & Leder	—
Pesticídy	—
Palmový olej	—
Tabak	❌
Géntechnológia	❌
Koncept klímy	—
Udržateľné lesníctvo	—
Recyklačné predpisy	✅
Ekologické obaly	❌
Nebezpečné látky	✅
Spotreba a účinnosť paliva	❌
Spotreba a efektívnosť vody	✅

Podiel žien zamestnancov	61
Podiel žien v manažmente	—
Podiel ázijských zamestnancov	—
Podiel ázijského manažmentu	—
Podiel hispánskych/latinoamerických zamestnancov	—
Podiel hispánskeho/latinského manažmentu	—
Podiel zamestnancov čiernej pleti	—
Podiel čierneho manažmentu	—
Podiel bielych zamestnancov	—
Podiel bieleho vedenia	—
Dospelých obsah	❌
Alkohol	❌
obrana	—
strelne zbrane	❌
Hazard	❌
Vojenské zmluvy	❌
Koncept ľudských práv	✅
Koncept ochrany údajov	—
Ochrana práce a zdravia	✅
katolícky	✅

Udržateľnostná správa	✅
Angažovanosť zainteresovaných strán	❌
Spätné volacie pravidlá	❌
Antimonopolné právo	❌

Burza	Pharma Mar Ticker
BME	PHM.MC
DÜSSELDORF	PMRA.DU
FRANKFURT	PMRA.F
LONDON	0RC6.L
MADRID	PHM.MC
MNÍCHOV	PMRA.MU
PNK	PHMMF

Pharma Mar Ticker	Pharma Mar FIGI
PHM:SM	BBG000F3LRQ5
PHM:SQ	BBG00BBLCS10
PHME:PO	BBG00BBVNW62
PHM1N:MM	BBG00BBVNWW3
PHM1N:MF	BBG00BBVNWX2
PHME:B3	BBG00BBVSVX9
PHME:L3	BBG00BBVT2X2
PHME:IX	BBG00BBVTHT4
PHME:EB	BBG00BBVTSR2
PHMMF:US	BBG00BBVVVW6
PHMMF:PQ	BBG00BBVVWB7
PHMMF:UV	BBG00BBVVWC6
PMRA:GR	BBG00BBVX640
PMRA:GF	BBG00BBVX668
PMRA:GD	BBG00BBVX686
PMRA:GS	BBG00BBVX6D0
PMRA:GM	BBG00BBVX6G7
PMRA:GB	BBG00BBVX6K2
PHM2EUR:EO	BBG00BC6MW94
PHM2EUR:XH	BBG00BC6MWD9
PHM2EUR:XF	BBG00BC6MWG6
PHM2EUR:XE	BBG00BC6MWJ3
PHM2EUR:XJ	BBG00BC6MWK1
PHM2EUR:XL	BBG00BC6MWL0
PHM2EUR:XG	BBG00BC6MWM9
PHM2EUR:XO	BBG00BC6MWN8
PHM2EUR:XA	BBG00BC6MWT2
PHM2EUR:E1	BBG00BC6MWV9
PHM2EUR:XT	BBG00BC6MWW8
PHM2EUR:XW	BBG00BC6MWX7
PHM2EUR:XU	BBG00BC6MWY6
PHM2EUR:XV	BBG00BC6MWZ5
PHM2EUR:EU	BBG00BC6MX10
PHME:S1	BBG00BLYVNR3
PHM2USD:EO	BBG00BQXJSL9
PHM2USD:XH	BBG00BQXJSP5
PHM2USD:XF	BBG00BQXJSR3
PHM2USD:XE	BBG00BQXJST1
PHM2USD:XJ	BBG00BQXJSV8
PHM2USD:XL	BBG00BQXJSW7
PHM2USD:XG	BBG00BQXJSX6
PHM2USD:XO	BBG00BQXJSY5
PHM2USD:XA	BBG00BQXJT37
PHM2USD:E1	BBG00BQXJT46
PHM2USD:XT	BBG00BQXJT55
PHM2USD:XW	BBG00BQXJT64
PHM2USD:XU	BBG00BQXJT73
PHM2USD:XV	BBG00BQXJT82
PHM2USD:EU	BBG00BQXJTC7
PHME:BQ	BBG00CWZT0V4
PMRA:QT	BBG00D8M3XH0
PHME:QX	BBG00F16YBH1
PMRA:TH	BBG00GXJ23L4
PHM2EUR:XM	BBG00J9WNBR9
PHM2EUR:XX	BBG00JN8G0V3
PHM2USD:XX	BBG00JN8GG75
PHM1N:MU	BBG00JX0QJT0
PHM2GBX:EO	BBG00KVTPH57
PHM2GBX:XH	BBG00KVTPH84
PHM2GBX:XF	BBG00KVTPHB0
PHM2GBX:XE	BBG00KVTPHD8
PHM2GBX:XJ	BBG00KVTPHF6
PHM2GBX:XL	BBG00KVTPHG5
PHM2GBX:XG	BBG00KVTPHH4
PHM2GBX:XO	BBG00KVTPHJ2
PHM2GBX:XA	BBG00KVTPHN7
PHM2GBX:E1	BBG00KVTPHP5
PHM2GBX:XT	BBG00KVTPHQ4
PHM2GBX:XW	BBG00KVTPHR3
PHM2GBX:XU	BBG00KVTPHS2
PHM2GBX:XV	BBG00KVTPHT1
PHM2GBX:XM	BBG00KVTPHV8
PHM2GBX:XQ	BBG00KVTPHX6
PHM2GBX:XX	BBG00KVTPHY5
PHM2GBX:XZ	BBG00KVTPHZ4
PHM2GBX:EU	BBG00KVTPJ17
PHMEUR:T2	BBG00N0091J6
PHME:QE	BBG00NL2WH99
PHME:T1	BBG00NLK4JY8
PHME:I2	BBG00NQCR2H2
PHMEUR:WT	BBG00NR92YN8
PHM2EUR:X2	BBG00Q5MNPH9
PHM2GBX:EP	BBG00WFC2YB7
PHM2GBX:EZ	BBG00WFC2YH1
PHME:TQ	BBG00XH531T0
PHM2USD:EP	BBG00XH531Y4
PHM2USD:EZ	BBG00XH53209
PMRA:GZ	BBG00XRJ4QN9
0RC6:LO	BBG00Y63DGS2
PHME:L1	BBG00Y92LFM0
PHME:S4	BBG00YJ81176
PMRA:LA	BBG018H9F9Z9
PMRA:LU	BBG018J32BQ9

Urob najlepšie investície svojho života

Cena

Cena

TickerPHM.MC

ISINES0169501022

WKNA2P9YT

Pharma Mar Akcia Obrat, EBIT, Zisk ES0169501022 · A2P9YT

Tržby, Zisk & EBIT

Porozumenie tržbám, EBIT a príjmu

Ročná analýza a porovnania

Využitie očakávaní pre investície

Investičné vhľady

Pharma Mar Tržby, zisk a história EBIT

Pharma Mar Akcie - Kľúčové ukazovatele

GuV

Tržby a rast

Hrubá marža

EBIT a marža EBIT

Príjem a rast

Počet akcií v obehu

Interpretácia ročných porovnaní

Očakávania a prognózy

Bilancia

Porozumenie bilancii

Aktíva

Záväzky

Vlastné imanie

Analýza rok za rokom

Interpretácia dát

Pharma Mar Akcie Marže ES0169501022 · A2P9YT

Marže

Počítať brutto maržu

Analýza marže EBIT

Pohľady na maržu tržieb

Interpretácia očakávaní

Porovnávacia analýza

Pharma Mar História marže

Pharma Mar Akciový obrat, EBIT, zisk na akciu ES0169501022 · A2P9YT

Tržby, EBIT a Zisk na akciu

Tržby na akciu

EBIT na akciu

Príjem na akciu

Očakávané hodnoty

Pharma Mar Tržby, zisk a EBIT na akciu História

Pharma Mar Akcia a analýza akcií

Pharma Mar Hodnotenie podľa historického KGV, EBIT a KUV

Pharma Mar Počet akcií ES0169501022 · A2P9YT

Tržby, EBIT a Zisk na akciu

Tržby na akciu

EBIT na akciu

Príjem na akciu

Očakávané hodnoty

Pharma Mar Akcie rozdelené

Pharma Mar Akcia Dividenda ES0169501022 · A2P9YT

Dividenda

Prehľad dividend

Interpretácia a využitie

Investičná stratégia

Pharma Mar História dividend

Pharma Mar Akcia Výplatná kvóta ES0169501022 · A2P9YT

Výplatná kvóta

Čo je ročná výplatná kvóta?

Ako interpretovať dáta

Použitie údajov pre investície

Pharma Mar História výplatných kvót

Pharma Mar Odhad ziskov

Pharma Mar Prekvapenia zisku

Eulerpool ESG hodnotenie pre akciu Pharma Mar

Eulerpool World ESG Rating (EESG©)

85/ 100

🌱 Environment

👫 Social

🏛️ Governance

Životné prostredie (Environment)

Sociálne (Social)

Riadenie spoločnosti (Governance)

Pharma Mar Akcie Štruktúra akcionárov

Pharma Mar Predstavenstvo a dozorná rada

Často kladené otázky k akcii Pharma Mar

What values and corporate philosophy does Pharma Mar represent?

Ticker
PHM.MC

ISIN
ES0169501022

WKN
A2P9YT